MADRIGAL PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Madrigal Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Madrigal Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 28, 2024 was 21.8M shares, a 10.5% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 21.8M +2.07M +10.5% Oct 28, 2024 10-Q 2024-10-31
Q2 2024 21.7M +3.24M +17.5% Aug 2, 2024 10-Q 2024-08-07
Q1 2024 21.3M +3.02M +16.5% May 3, 2024 10-Q 2024-05-07
Q3 2023 19.7M +2.64M +15.4% Nov 1, 2023 10-Q 2023-11-06
Q2 2023 18.5M +1.37M +8% Aug 3, 2023 10-Q 2023-08-08
Q1 2023 18.3M +1.19M +6.93% May 5, 2023 10-Q 2023-05-09
Q3 2022 17.1M +6.31K +0.04% Nov 1, 2022 10-Q 2022-11-03
Q2 2022 17.1M +503K +3.03% Aug 1, 2022 10-Q 2022-08-04
Q1 2022 17.1M +519K +3.13% May 5, 2022 10-Q 2022-05-09
Q3 2021 17.1M +1.63M +10.5% Nov 2, 2021 10-Q 2021-11-04
Q2 2021 16.6M +1.16M +7.53% Jul 30, 2021 10-Q 2021-08-05
Q1 2021 16.6M +1.16M +7.49% Apr 30, 2021 10-Q 2021-05-06
Q3 2020 15.5M +37.3K +0.24% Oct 30, 2020 10-Q 2020-11-05
Q2 2020 15.4M +11.8K +0.08% Jul 31, 2020 10-Q 2020-08-06
Q1 2020 15.4M +10.8K +0.07% May 4, 2020 10-Q 2020-05-07
Q3 2019 15.4M +35.8K +0.23% Nov 1, 2019 10-Q 2019-11-06
Q2 2019 15.4M +1.18M +8.25% Aug 1, 2019 10-Q 2019-08-07
Q1 2019 15.4M +1.19M +8.37% May 2, 2019 10-Q 2019-05-08
Q3 2018 15.4M +2.9M +23.2% Nov 1, 2018 10-Q 2018-11-06
Q2 2018 14.3M +1.76M +14% May 31, 2018 10-Q 2018-05-08
Q1 2018 14.2M +2.06M +16.9% Mar 8, 2018 10-K 2018-03-13
Q3 2017 12.5M +926K +8% Nov 3, 2017 10-Q 2017-11-09
Q2 2017 12.5M -125M -90.9% Aug 4, 2017 10-Q 2017-08-10
Q1 2017 12.2M -126M -91.2% Mar 24, 2017 10-K 2017-03-31
Q3 2016 11.6M -126M -91.6% Nov 11, 2016 10-Q/A 2017-03-31
Q2 2016 138M +1.36M +1% Jul 15, 2016 10-Q 2016-07-20
Q1 2016 138M +28.7M +26.3% Mar 10, 2016 10-K 2016-03-15
Q3 2015 138M +28.9M +26.5% Nov 2, 2015 10-Q 2015-11-05
Q2 2015 136M +32.1M +30.7% Aug 3, 2015 10-Q 2015-08-06
Q1 2015 109M +23.7M +27.7% Mar 6, 2015 10-K 2015-03-12
Q3 2014 109M +39.8M +57.6% Oct 31, 2014 10-Q 2014-11-06
Q2 2014 104M +35.3M +51.1% Aug 1, 2014 10-Q 2014-08-06
Q1 2014 85.4M +16.4M +23.7% Mar 6, 2014 10-K 2014-03-11
Q3 2013 69.1M +7.21M +11.6% Oct 31, 2013 10-Q 2013-11-04
Q2 2013 69.1M +7.22M +11.7% Jul 26, 2013 10-Q 2013-08-01
Q1 2013 69.1M +11.4M +19.8% Mar 8, 2013 10-K 2013-03-14
Q3 2012 61.9M +12.4M +25.1% Nov 1, 2012 10-Q 2012-11-06
Q2 2012 61.8M +12.3M +24.9% Jul 27, 2012 10-Q 2012-08-02
Q1 2012 57.6M Apr 30, 2012 10-Q 2012-05-03
Q3 2011 49.5M Oct 28, 2011 10-Q 2011-11-03
Q2 2011 49.5M Jul 29, 2011 10-Q 2011-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.